DekaBank Deutsche Girozentrale - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 116 filers reported holding GW PHARMACEUTICALS PLC in Q4 2015. The put-call ratio across all filers is 2.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$217,000
-84.1%
1,000
-91.6%
0.00%
-80.0%
Q4 2020$1,364,000
+12.4%
11,860
-4.8%
0.01%0.0%
Q3 2020$1,213,000
+1247.8%
12,460
+1322.4%
0.01%
+400.0%
Q4 2019$90,000
-96.1%
876
-95.6%
0.00%
-92.9%
Q3 2019$2,315,000
-46.1%
19,886
-21.1%
0.01%
-36.4%
Q2 2019$4,292,000
+89.1%
25,216
+62.8%
0.02%
+57.1%
Q1 2019$2,270,000
+85.2%
15,485
+19.2%
0.01%
+75.0%
Q4 2018$1,226,000
-46.0%
12,993
-16.1%
0.01%
-38.5%
Q3 2018$2,270,000
+6.1%
15,485
+0.2%
0.01%
-7.1%
Q2 2018$2,139,000
+81.1%
15,450
+44.4%
0.01%
+75.0%
Q1 2018$1,181,000
+5.2%
10,700
-2.0%
0.01%
-11.1%
Q4 2017$1,123,0000.0%10,9200.0%0.01%0.0%
Q3 2017$1,123,000
+2.9%
10,9200.0%0.01%0.0%
Q2 2017$1,091,000
+22.9%
10,920
+49.2%
0.01%
+12.5%
Q1 2017$888,000
+0.1%
7,320
-7.8%
0.01%
-11.1%
Q4 2016$887,000
-7.0%
7,940
+8.2%
0.01%
-18.2%
Q3 2016$954,000
+39.5%
7,3400.0%0.01%
+37.5%
Q2 2016$684,000
+47.4%
7,340
+12.2%
0.01%
+60.0%
Q1 2016$464,000
-12.3%
6,540
-14.4%
0.01%
-16.7%
Q4 2015$529,000
-23.2%
7,640
+1.3%
0.01%
-25.0%
Q3 2015$689,000
-2.3%
7,540
+31.4%
0.01%0.0%
Q2 2015$705,000
+39.3%
5,740
+3.4%
0.01%
+33.3%
Q1 2015$506,0005,5500.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders